The Fred Report - Sector Review June 2017

View a Printer Friendly version of this page, allowing you to print the page.

XLV is a breakout after an extended period of under performance. Biotech, one of our bellwethers for XLV, has improved. IYW has had strong selling since the last Sector Review, and this sector has been extended for some time. The risk is that the “Fang Stocks” are moving from strong to weak hands and could do badly for a while.

Sorry this page is available to subscribers only.
If you're not a subscriber why not
join today?

If you are already a subscriber, please login.

If you believe you should be able to view this area, then please contact us and we will try to rectify this issue as soon as possible.

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.




Who is Fred Meissner, CMT?
Listen here:

The FRED Report is not authorized, endorsed, or affiliated with the Federal Reserve of St Louis and its FRED Economic Data.